Skip to main content

IRB Barcelona takes centre stage at the 34th Catalan National Research Awards

Images

Participants

Contact

Image
Press & Communications Section Head
Tel.+34 93 40 37255
  • Dr. Eduard Batlle receives the Catalan National Research Award.
  • IRB Barcelona and ICREA are presented with the Catalan National Innovation Award for the foundation of Nuage Therapeutics.

On Thursday 20 June,  Dr. Eduard Batlle, ICREA research professor and head of the Colorectal Cancer lab at IRB Barcelona was presented with the 2023 Catalan National Research Award. This accolade highlights his pioneering work in characterising the architecture of colorectal cancer and discoveries in metastatic dissemination that have led to new therapeutic treatments that are currently in clinical trials.

Additionally, IRB Barcelona and ICREA received the Catalan National Innovation Award for the foundation of the spin-off Nuage Therapeutics, which focuses on the development of innovative drugs for castration-resistant prostate cancer. Founded by researchers Dr. Xavier Salvatella, Dr. Mateusz Biesaga, Dr. Denes Hnisz, and Dr. Judit Anido, Nuage Therapeutics uses a patented technological platform leveraging biomolecular condensation to target intrinsically disordered proteins, a previously untreatable class of therapeutic targets.

The President of the Generalitat, Pere Aragonès, and the Minister of Research and Universities, Joaquim Nadal, presided over the award ceremony at the Teatre Nacional de Catalunya, which was attended by over 700 representatives from the Catalan research and innovation system.

Now in their 34th year, these awards are the highest distinction in the field of research in Catalonia and they promote the social recognition of science and innovation. The awards given to IRB Barcelona underscore its scientific excellence and commitment to knowledge transfer for global health improvement.

 

For more information, see the news about the award announcement here.

About IRB Barcelona

The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).